Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mylan NV (NASDAQ:MYL)

38.12
Delayed Data
As of Sep 30
 -0.35 / -0.91%
Today’s Change
37.59
Today|||52-Week Range
55.51
-29.50%
Year-to-Date

Today’s Trading

Previous close38.47
Today’s open38.33
Day’s range37.85 - 38.83
Volume7,298,747
Average volume (3 months)5,606,522
Market cap$20.6B
Dividend yield--
Data as of 3:59pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)-27.35%
Earnings growth (this year)+15.31%
Earnings growth (next 5 years)+9.26%
Revenue growth (last year)+21.91%
P/E ratio16.4
Price/Sales2.84
Price/Book1.93

Competitors

 Today’s
change
Today’s
% change
VRTXVertex Pharmaceutica...+2.21+2.60%
INCYIncyte Corp+2.00+2.17%
BMRNBiomarin Pharmaceuti...-0.26-0.28%
ZTSZoetis Inc+0.99+1.94%
Data as of 4:02pm ET, 09/30/2016

Financials

Next reporting dateOctober 27, 2016
EPS forecast (this quarter)$1.57
Annual revenue (last year)$9.5B
Annual profit (last year)$847.6M
Net profit margin8.95%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Hatfield, Hertfordshire

Forecasts

Search for Jobs